Influx Healthtech IPO subscribed overall 201.35 times on the last day, while A retail quota was subscribed 117.68 times, QIB subscribed 137.87 and NII quota subscribed 481.10 times respectively.
Details About Influx Healthtech
Influx Healthtech got approval from SEBI for an IPO of ₹58.57 crores via IPO that comprises a fresh issue of ₹48.00 crores and offer for sale up to 11,00,400 equity shares with face value of ₹10 each. The company has set up a price band between ₹91 to ₹96 per share.
In this IPO, a total of 1200 shares were available in 1 lot size for the minimum Retail category and for the maximum retail category 1200 shares in 1 lot size, while S-HNI (Min) total of 2400 shares in 2 lot size.
Maximum and Minimum retailer investors has to pay ₹1,15,200.
S-HNI categories have to pay ₹2,30,400.
Subscription duration of Influx Healthtech
Influx Healthtech IPO was opened for subscription on June 18, 2025, and was closed for subscription on June 20, 2025. The Allotment status of Influx Healthtech was finalized on June 23, 2025, whereas the IPO listing is to be announced on June 25, 2025.
Funds Deployment of This Company
The company plans to use the money raised from the new shares for the following purposes:
- Funding capital expenditure requirements for the setting up of a manufacturing facility for Nutraceutical Division
- Funding capital expenditure requirements for setting up of manufacturing facility for Veterinary Food Division
- Purchase of Machineries for Homecare and Cosmetic Division
- General corporate purposes.
About Influx Healthtech IPO
Influx Healthcare Limited was incorporated in 2020. The company is one of the leading companies in terms of healthcare-focused companies specializing in contract manufacturing.
They are offering excellent services to clients from various industries; therefore, it has built a robust reputation as a trusted contract Development and Manufacturing Organization (CDMO).
The company has manufacturing facilities in Thane, Maharashtra, covering approximately 9,676 sq. ft., 13,000 sq. ft., and 14,000 sq. ft. It is recognized for producing its products with a strong focus on safety, quality, and regulatory compliance.
Influx Healthcare works in different areas like dietary and nutritional supplements, cosmetics, ayurvedic/herbal products, veterinary feed supplements, and homecare items.
Influx Healthtech IPO Financial Background
It’s has a revenue of 2025 is ₹104.99 crores, while ₹100.10 crore in 2024. Moreover, The company reported profit of ₹13.37 crores in 2025 against profit of ₹11.22 crores in 2024.
